Goldman Sachs’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-267,308
| Closed | -$2.65M | – | 6294 |
|
|
2023
Q1 | $2.65M | Buy |
267,308
+118,075
| +79% | +$1.17M | ﹤0.01% | 3627 |
|
|
2022
Q4 | $1.49M | Sell |
149,233
-746,980
| -83% | -$5.57M | ﹤0.01% | 4150 |
|
|
2022
Q3 | $4.94M | Buy |
896,213
+123,495
| +16% | +$685K | ﹤0.01% | 3147 |
|
|
2022
Q2 | $2.82M | Sell |
772,718
-49,269
| -6% | -$233K | ﹤0.01% | 3737 |
|
|
2022
Q1 | $4.97M | Buy |
821,987
+169,422
| +26% | +$1.03M | ﹤0.01% | 3362 |
|
|
2021
Q4 | $5.5M | Buy |
652,565
+10,594
| +2% | +$92.5K | ﹤0.01% | 3312 |
|
|
2021
Q3 | $5.82M | Buy |
641,971
+4,716
| +0.7% | +$40.5K | ﹤0.01% | 3228 |
|
|
2021
Q2 | $5.16M | Sell |
637,255
-6,936
| -1% | -$47.6K | ﹤0.01% | 3307 |
|
|
2021
Q1 | $3.55M | Buy |
644,191
+20,349
| +3% | +$101K | ﹤0.01% | 3455 |
|
|
2020
Q4 | $2.12M | Buy |
623,842
+316,372
| +103% | +$833K | ﹤0.01% | 3684 |
|
|
2020
Q3 | $520K | Sell |
307,470
-470
| -0.2% | -$709 | ﹤0.01% | 4463 |
|
|
2020
Q2 | $503K | Buy |
307,940
+153,970
| +100% | +$306K | ﹤0.01% | 4375 |
|
|
2020
Q1 | $296K | Hold |
153,970
| – | – | ﹤0.01% | 4514 |
|
|
2019
Q4 | $439K | Sell |
153,970
-900
| -0.6% | -$2.61K | ﹤0.01% | 4575 |
|
|
2019
Q3 | $510K | Buy |
154,870
+421
| +0.3% | +$1.33K | ﹤0.01% | 4444 |
|
|
2019
Q2 | $502K | Hold |
154,449
| – | – | ﹤0.01% | 4394 |
|
|
2019
Q1 | $578K | Buy |
154,449
+34,249
| +28% | +$120K | ﹤0.01% | 4356 |
|
|
2018
Q4 | $415K | Buy |
+120,200
| New | +$593K | ﹤0.01% | 4466 |
|
|
2017
Q4 | – | Sell |
-14,642
| Closed | -$69K | – | 6747 |
|
|
2017
Q3 | $69K | Buy |
+14,642
| New | +$77.3K | ﹤0.01% | 6182 |
|
|
2016
Q2 | – | Sell |
-325
| Closed | -$5K | – | 7318 |
|
|
2016
Q1 | $5K | Sell |
325
-72
| -18% | -$1K | ﹤0.01% | 6979 |
|
|
2015
Q4 | $7K | Hold |
397
| – | – | ﹤0.01% | 7019 |
|
|
2015
Q3 | $6K | Hold |
397
| – | – | ﹤0.01% | 7190 |
|
|
2015
Q2 | $8K | Buy |
+397
| New | +$39.3K | ﹤0.01% | 7172 |
|
Goldman Sachs's APEN Position: Q2 2023 in Review
Goldman Sachs sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 267,308 shares — an estimated $2.65M sold.
Goldman Sachs first reported a position in APEN in Q2 2015 and held it in 23 quarters. The position peaked at $5.82M in Q3 2021. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Goldman Sachs reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Goldman Sachs sold 267,308 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $2.65M.
- Goldman Sachs first reported a position in Apollo Endosurgery, Inc. in Q2 2015 and held it in 23 quarters.
- Goldman Sachs's Apollo Endosurgery, Inc. position peaked at $5.82M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.